KEVIN P STARR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KEVIN P STARR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KEVIN P STARR. KEVIN P STARR is a Director in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and a Director in ZAFGEN, INC. ($ZFGN) and a 10% Owner in CytomX Therapeutics, Inc. ($CTMX) and a Director in MyoKardia Inc ($MYOK) and a 10% Owner in Blueprint Medicines Corp ($BPMC) and a in Sage Therapeutics, Inc. ($SAGE) and a Director in Sage Therapeutics, Inc. ($SAGE) and a 10% Owner in Global Blood Therapeutics, Inc. ($GBT) and a Director in Global Blood Therapeutics, Inc. ($GBT) and a 10% Owner in Editas Medicine, Inc. ($EDIT).
Address: C/O ALNYLAM PHARMACEUTICALS, INC. 300 THIRD STREET CAMBRIDGE 02142 MA
Companies in which KEVIN P STARR is an Insider
ALNYLAM PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KEVIN P STARR: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 06 2017
$ALNY Market Capitalization: $3.49B
$ALNY Previous Close: $40.46
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Blueprint Medicines Corp
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KEVIN P STARR: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 21 2016
$BPMC Market Capitalization: $979.55M
$BPMC Previous Close: $35.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CytomX Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KEVIN P STARR: 10% Owner
Holdings: 31,419 shares
Current Value: $361,319
Latest Transaction: Apr 14 2017
$CTMX Market Capitalization: $410.61M
$CTMX Previous Close: $11.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Editas Medicine, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of KEVIN P STARR: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 07 2016
$EDIT Market Capitalization: $636.78M
$EDIT Previous Close: $18.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Global Blood Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KEVIN P STARR: 10% Owner, Director
Holdings: 82,544 shares
Current Value: $1,337,213
Latest Transaction: Dec 20 2016
$GBT Market Capitalization: $626.91M
$GBT Previous Close: $16.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Larimar Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KEVIN P STARR: Director
Holdings: 370,323 shares
Current Value: $1,518,324
Latest Transaction: Sep 25 2015
$LRMR Market Capitalization: $109.05M
$LRMR Previous Close: $4.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MyoKardia, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KEVIN P STARR: Director
Holdings: 885,104 shares
Current Value: $10,621,248
Latest Transaction: Mar 07 2018
$MYOK Market Capitalization: $375.56M
$MYOK Previous Close: $12.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sage Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KEVIN P STARR:
Holdings: 320,659 shares
Current Value: $15,295,434
Latest Transaction: Jun 17 2021
$SAGE Market Capitalization: $1.75B
$SAGE Previous Close: $47.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of KEVIN P STARR
Sentiment: All, ALNY, BPMC, CTMX, EDIT, GBT, LRMR, MYOK, SAGE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 2021 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Buy | P | 56.05 | 17,842 | 999,983 | 320,659 | 302.8 K to 320.7 K (+5.89 %) | |
| Jun 11 2020 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Option Exercise | A | 36.47 | 10,000 | 364,700 | 10,000 | ||
| Jun 06 2019 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Option Exercise | A | 177.41 | 10,000 | 1,774,100 | 10,000 | ||
| Apr 19 2018 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | S | 168.28 | 24,000 | 4,038,650 | 302,817 | 326.8 K to 302.8 K (-7.34 %) |
| Apr 19 2018 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | S | 169.25 | 35,000 | 5,923,600 | 326,817 | 361.8 K to 326.8 K (-9.67 %) |
| Mar 07 2018 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | J | 0.00 | 2,000,000 | 0 | 885,104 | 2.9 M to 885.1 K (-69.32 %) |
| Feb 20 2018 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 510,554 | 0 | 37,362 | 547.9 K to 37.4 K (-93.18 %) |